Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease

Published:2017-02-07 Issue:7 Volume:45 Page:941-950
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Mahadevan U.¹,Vermeire S.²,Lasch K.³,Abhyankar B.⁴,Bhayat F.⁴,Blake A.⁴,Dubinsky M.⁵

Affiliation:

1. Center for Colitis and Crohn's Disease; University of California San Francisco; San Francisco CA USA

2. University Hospital Gasthuisberg; Leuven Belgium

3. Takeda Pharmaceuticals USA, Inc.; Deerfield IL USA

4. Takeda Development Centre Europe Ltd; London UK

5. Department of Pediatrics; Susan and Leonard Feinstein IBD Clinical Center; Icahn School of Medicine at Mount Sinai; New York NY USA

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13960/fullpdf

Reference40 articles.

1. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

2. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013

3. The safety of vedolizumab for ulcerative colitis and Crohn's disease;Colombel;Gut,2016

4. The binding specificity and selective antagonism of vedolizumab, an anti-α4β7 integrin therapeutic antibody in development for inflammatory bowel diseases;Soler;J Pharmacol Exp Ther,2009

5. IBD and pregnancy;Calderwood;MedGenMed,2004

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conception, pregnancy and inflammatory bowel disease—Current concepts for the practising clinician;Indian Journal of Gastroenterology;2024-05-15

2. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

3. New drugs for the treatment of IBD during conception, pregnancy, and lactation;Digestive and Liver Disease;2024-02

4. Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-01

5. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy;Saudi Journal of Gastroenterology;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3